151 – 160 of 381
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
(
- Contribution to journal › Article
-
Mark
Favorable Outcome In ALK Negative Anaplastic Large Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT) a Prospective Study by the Nordic Lymphoma Group (NLG T 01)
(
- Contribution to journal › Published meeting abstract
-
Mark
Endothelial protein C receptor-expressing hematopoietic stem cells reside in the perisinusoidal niche in fetal liver
(
- Contribution to journal › Article
-
Mark
Human Embryonic Stem Cell Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune Modulatory Function Implications for off the Shelf ES MSC Therapies
(
- Contribution to journal › Published meeting abstract
-
Mark
R CHOEP 14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3 Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years
(
- Contribution to journal › Published meeting abstract
-
Mark
Chronic RPS19 Deficiency Leads to Bone Marrow Failure In a Mouse Model for Diamond Blackfan Anemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Genome Wide Array Based Methylation Profiling Reveals Preferential Methylation of Homeobox Transcription Factor Genes In Mantle Cell Lymphoma and Pro Apoptotic Genes In Chronic Lymphocytic Leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good Prognosis Diffuse Large B Cell Lymphoma (DLBCL) Results of the 6 Year Follow up of the Mint Study of the Mabthera International Trial (Mint) Group
(
- Contribution to journal › Published meeting abstract
-
Mark
The IgG specific endoglycosidase EndoS inhibits both cellular and complement mediated autoimmune hemolysis.
(
- Contribution to journal › Article
-
Mark
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy
(
- Contribution to journal › Article